Shi Du

1.9k total citations · 2 hit papers
23 papers, 1.3k citations indexed

About

Shi Du is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Shi Du has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Biomaterials. Recurrent topics in Shi Du's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immunotherapy and Immune Responses (5 papers). Shi Du is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Immunotherapy and Immune Responses (5 papers). Shi Du collaborates with scholars based in United States, China and India. Shi Du's co-authors include Yizhou Dong, Xucheng Hou, Jinyue Yan, Binbin Deng, David W. McComb, Weiyu Zhao, Chunxi Zeng, Yonger Xue, Wenqing Li and Xinfu Zhang and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shi Du

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy

2022 178 citations Jin-Qing Liu, Chengxiang Zhang et al. Journal of Controlled Release profile →
LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing

2024 46 citations Yonger Xue, Yuebao Zhang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shi Du United States	14	904	410	229	190	179	23	1.3k
Chunxi Zeng United States	15	1.0k 1.1×	355 0.9×	219 1.0×	215 1.1×	147 0.8×	26	1.4k
Zhongfeng Ye United States	13	1.1k 1.2×	376 0.9×	224 1.0×	134 0.7×	180 1.0×	18	1.4k
Kelsey L. Swingle United States	19	1.1k 1.2×	287 0.7×	248 1.1×	124 0.7×	249 1.4×	24	1.5k
Allen Yujie Jiang United States	8	856 0.9×	259 0.6×	121 0.5×	166 0.9×	106 0.6×	9	1.1k
Derfogail Delcassian United States	10	913 1.0×	460 1.1×	216 0.9×	147 0.8×	163 0.9×	12	1.3k
Edo Kon Israel	8	653 0.7×	240 0.6×	138 0.6×	153 0.8×	164 0.9×	10	972
Ranit Kedmi Israel	9	1.1k 1.2×	282 0.7×	173 0.8×	106 0.6×	135 0.8×	12	1.3k
Blessing Crimeen‐Irwin Australia	16	904 1.0×	656 1.6×	121 0.5×	125 0.7×	351 2.0×	23	1.6k
Yaqing Qie United States	12	835 0.9×	597 1.5×	429 1.9×	280 1.5×	212 1.2×	20	1.7k

Countries citing papers authored by Shi Du

Since Specialization

Citations

This map shows the geographic impact of Shi Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Du more than expected).

Fields of papers citing papers by Shi Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Du. The network helps show where Shi Du may publish in the future.

Co-authorship network of co-authors of Shi Du

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Du. A scholar is included among the top collaborators of Shi Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Du. Shi Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuebao, Kaiyuan Guo, Shi Du, et al.. (2025). Aminophosphonate-Derived lipid nanoparticles enable circular RNA delivery for functional recovery after spinal cord injury. Materials Today. 91. 148–157.

Ren, Qiang, Siqi Zhang, Meng Shi, et al.. (2025). Administration route-commended concise organ-selective mRNA transfection (ACCOST) by cyclic disulfide-primed short polyethylenimine. Nano Today. 63. 102741–102741.

Dai, Yu, Yang Li, Guosheng Cao, et al.. (2025). Combination therapy and drug co-delivery systems for atherosclerosis. Journal of Controlled Release. 381. 113543–113543. 1 indexed citations

Xue, Yonger, Yuebao Zhang, Yichen Zhong, et al.. (2024). LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing. Nature Communications. 15(1). 739–739. 46 indexed citations breakdown →

Yan, Jinyue, Diana D. Kang, Chang Wang, et al.. (2024). LPA1 antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities. Nano Research. 17(10). 9095–9102. 1 indexed citations

Lv, Shuai, et al.. (2024). Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment. Journal of Controlled Release. 377. 781–793. 2 indexed citations

Yang, Can, Yu Dai, Wei Liu, et al.. (2024). Novel drug delivery systems for hirudin-based product development and clinical applications. International Journal of Biological Macromolecules. 287. 138533–138533. 1 indexed citations

Wang, Shuting, et al.. (2024). Preclinical Advances in LNP-CRISPR Therapeutics for Solid Tumor Treatment. Cells. 13(7). 568–568. 4 indexed citations

Du, Shi, Wenqing Li, Yuebao Zhang, et al.. (2023). Cholesterol‐Amino‐Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self‐Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice. Advanced Science. 10(11). e2300188–e2300188. 36 indexed citations

10.

Zhang, Yuebao, Xucheng Hou, Shi Du, et al.. (2023). Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy. Nature Nanotechnology. 18(11). 1364–1374. 66 indexed citations

11.

Du, Shi, et al.. (2023). Adoptive cell therapy for cancer treatment. SHILAP Revista de lepidopterología. 3(4). 20210058–20210058. 62 indexed citations

12.

Zhong, Yichen, Shi Du, & Yizhou Dong. (2023). mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B. 13(4). 1348–1357. 31 indexed citations

13.

Zhang, Yuebao, Jinyue Yan, Xucheng Hou, et al.. (2023). STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2. Nano Letters. 23(7). 2593–2600. 59 indexed citations

14.

Liu, Jin-Qing, Chengxiang Zhang, Xinfu Zhang, et al.. (2022). Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. Journal of Controlled Release. 345. 306–313. 178 indexed citations breakdown →

15.

Yan, Jinyue, Yuebao Zhang, Shi Du, et al.. (2022). Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity. Advanced Materials. 34(47). e2207486–e2207486. 45 indexed citations

16.

Li, Wenqing, Xinfu Zhang, Chengxiang Zhang, et al.. (2021). Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy. Nature Communications. 12(1). 7264–7264. 88 indexed citations

17.

Zhao, Weiyu, Chunxi Zeng, Jinyue Yan, et al.. (2021). Construction of Messenger RNA (mRNA) Probes Delivered By Lipid Nanoparticles to Visualize Intracellular Protein Expression and Localization at Organelles. Advanced Materials. 33(45). e2103131–e2103131. 9 indexed citations

18.

Zhang, Xinfu, Weiyu Zhao, Giang N. Nguyen, et al.. (2020). Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing. Science Advances. 6(34). 151 indexed citations

19.

Zhao, Pengxuan, Xucheng Hou, Jinyue Yan, et al.. (2020). Long-term storage of lipid-like nanoparticles for mRNA delivery. Bioactive Materials. 5(2). 358–363. 188 indexed citations

20.

Hou, Xucheng, Xinfu Zhang, Weiyu Zhao, et al.. (2020). Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nature Nanotechnology. 15(1). 41–46. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact